$COLL
COLLEGIUM PHARMACEUTICAL, INC Stock $coll

$coll Overview Financials Valuation SEC Filings Company Website

2019 Form 10-K Financial Statement

#000155837020001625 Filed on February 27, 2020

Income Statement

Concept	2019	2018 Q4	2018 Q3
Revenue	$296.7M	$73.43M	$70.18M
YoY Change	5.81%	580.51%	487.25%
Cost Of Revenue	$193.7M	$29.73M	$46.01M
YoY Change	16.89%	2627.16%	8264.91%
Gross Profit	$103.0M	$43.70M	$24.17M
YoY Change	-10.19%	350.53%	112.01%
Gross Profit Margin	34.73%	59.52%	34.44%
Selling, General & Admin	$116.4M	$30.45M	$33.45M
YoY Change	-8.13%	21.37%	46.96%
% of Gross Profit	113.01%	69.68%	138.39%
Research & Development	$10.34M	$2.249M	$1.907M
YoY Change	19.39%	2.69%	-7.87%
% of Gross Profit	10.03%	5.15%	7.89%
Depreciation & Amortization	$731.0K	$15.90M	$32.50M
YoY Change	-31.94%	15800.0%	16150.0%
% of Gross Profit	0.71%	36.38%	134.47%
Operating Expenses	$126.8M	$32.70M	$35.36M
YoY Change	-6.37%	19.82%	42.39%
Operating Profit	-$23.75M	$11.00M	-$11.19M
YoY Change	14.81%	-162.54%	-16.71%
Interest Expense	$909.0K	$2.404M	$5.868M
YoY Change	-95.48%	1235.56%	3351.76%
% of Operating Profit		21.85%
Other Income/Expense, Net
YoY Change
Pretax Income	-$22.72M	$9.090M	-$16.50M
YoY Change	-41.93%	-152.24%	24.43%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$22.72M	$9.086M	-$16.50M
YoY Change	-41.93%	-152.22%	24.45%
Net Earnings / Revenue	-7.66%	12.37%	-23.52%
Basic Earnings Per Share	-$0.68	$0.27	-$0.50
Diluted Earnings Per Share	-$0.68	$0.27	-$0.50
COMMON SHARES
Basic Shares Outstanding	33.45M	33.25M	33.01M
Diluted Shares Outstanding	33.45M	33.77M	33.01M

Balance Sheet

Concept	2019	2018 Q4	2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$170.0M	$146.6M	$139.8M
YoY Change	15.96%	23.5%	29.93%
Cash & Equivalents	$170.0M	$146.6M	$139.8M
Short-Term Investments
Other Short-Term Assets	$3.100M	$1.008M	$3.400M
YoY Change	-39.22%	-66.4%	-17.07%
Inventory	$9.600M	$7.817M	$9.200M
Prepaid Expenses		$3.035M
Receivables	$73.00M	$77.95M	$66.50M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$255.7M	$237.5M	$219.0M
YoY Change	7.66%	77.91%	84.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$20.90M	$9.274M	$6.000M
YoY Change	124.73%	415.22%	275.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$200.0K	$204.0K	$200.0K
YoY Change	0.0%	-32.0%	-33.33%
Total Long-Term Assets	$50.60M	$53.73M	$427.5M
YoY Change	-5.77%	2458.71%	11150.0%
TOTAL ASSETS
Total Short-Term Assets	$255.7M	$237.5M	$219.0M
Total Long-Term Assets	$50.60M	$53.73M	$427.5M
Total Assets	$306.3M	$291.2M	$646.5M
YoY Change	5.19%	114.78%	426.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.200M	$12.15M	$11.70M
YoY Change	-49.18%	113.16%	134.0%
Accrued Expenses	$191.7M	$30.55M	$151.4M
YoY Change	9.36%	25.72%	684.46%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.800M	$1.600M	$800.0K
YoY Change	137.5%	6.67%	-61.9%
Total Short-Term Liabilities	$201.8M	$189.1M	$280.2M
YoY Change	6.72%	500.4%	961.36%
LONG-TERM LIABILITIES
Long-Term Debt	$7.700M	$9.900M	$10.70M
YoY Change	-22.22%
Other Long-Term Liabilities	$9.400M	$676.0K	$284.8M
YoY Change	1242.86%
Total Long-Term Liabilities	$17.10M	$676.0K	$295.5M
YoY Change	61.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$201.8M	$189.1M	$280.2M
Total Long-Term Liabilities	$17.10M	$676.0K	$295.5M
Total Liabilities	$218.9M	$199.7M	$575.7M
YoY Change	9.61%	533.84%	2080.68%
SHAREHOLDERS EQUITY
Retained Earnings		-$337.2M
YoY Change
Common Stock		$33.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$87.40M	$91.59M	$70.78M
YoY Change
Total Liabilities & Shareholders Equity	$306.3M	$291.2M	$646.5M
YoY Change	5.19%	114.78%	426.89%

Cashflow Statement

Concept	2019	2018 Q4	2018 Q3
OPERATING ACTIVITIES
Net Income	-$22.72M	$9.086M	-$16.50M
YoY Change	-41.93%	-152.22%	24.45%
Depreciation, Depletion And Amortization	$731.0K	$15.90M	$32.50M
YoY Change	-31.94%	15800.0%	16150.0%
Cash From Operating Activities	$27.78M	$42.30M	$41.80M
YoY Change	-83.6%	-418.05%	-434.4%
INVESTING ACTIVITIES
Capital Expenditures	$6.438M	-$1.800M	-$2.700M
YoY Change	17.55%	800.0%	800.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$6.438M	-$1.800M	-$2.700M
YoY Change	-73.56%	800.0%	800.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.041M	-33.70M	-33.00M
YoY Change	-101.74%	-236.99%	-454.84%
NET CHANGE
Cash From Operating Activities	27.78M	42.30M	41.80M
Cash From Investing Activities	-6.438M	-1.800M	-2.700M
Cash From Financing Activities	2.041M	-33.70M	-33.00M
Net Change In Cash	23.39M	6.800M	6.100M
YoY Change	-16.0%	-38.74%	-274.29%
FREE CASH FLOW
Cash From Operating Activities	$27.78M	$42.30M	$41.80M
Capital Expenditures	$6.438M	-$1.800M	-$2.700M
Free Cash Flow	$21.35M	$44.10M	$44.50M
YoY Change	-86.98%	-436.64%	-464.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Amount Liability FairValueDisclosureOffbalanceSheetRisksAmountLiability	0
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances	7204000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	16.00
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3955887
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33678840
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0001267565
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2018Q4	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33265629
CY2019Q4	us-gaap	Fair Value Liabilities Level2 To Level1 Transfers Amount FairValueLiabilitiesLevel2ToLevel1TransfersAmount	0
CY2018	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0
CY2018	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	0
CY2018	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3	0
CY2018	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2019Q4	us-gaap	Fair Value Assets Level2 To Level1 Transfers Amount FairValueAssetsLevel2ToLevel1TransfersAmount	0
CY2018Q4	us-gaap	Fair Value Liabilities Level1 To Level2 Transfers Amount FairValueLiabilitiesLevel1ToLevel2TransfersAmount	0
CY2019Q4	us-gaap	Fair Value Liabilities Level1 To Level2 Transfers Amount FairValueLiabilitiesLevel1ToLevel2TransfersAmount	0
CY2018Q4	us-gaap	Fair Value Liabilities Level2 To Level1 Transfers Amount FairValueLiabilitiesLevel2ToLevel1TransfersAmount	0
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3	0
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Document Annual Report DocumentAnnualReport	true
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2019	dei	Document Transition Report DocumentTransitionReport	false
CY2019	dei	Entity File Number EntityFileNumber	001-37372
CY2019	dei	Entity Registrant Name EntityRegistrantName	Collegium Pharmaceutical, Inc
CY2019	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	VA
CY2019	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	03-0416362
CY2019	dei	Entity Address Address Line1 EntityAddressAddressLine1	100 Technology Center Drive
CY2019	dei	Entity Address City Or Town EntityAddressCityOrTown	Stoughton
CY2019	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2019	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02072
CY2019	dei	City Area Code CityAreaCode	781
CY2019	dei	Local Phone Number LocalPhoneNumber	713-3699
CY2019	dei	Security12b Title Security12bTitle	Common stock
CY2019	dei	Trading Symbol TradingSymbol	COLL
CY2019	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2019	dei	Entity Small Business EntitySmallBusiness	false
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019Q2	dei	Entity Public Float EntityPublicFloat	416000000.0
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	34050862
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	170019000
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	146633000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	72953000
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	77946000
CY2019Q4	us-gaap	Inventory Net InventoryNet	9643000
CY2018Q4	us-gaap	Inventory Net InventoryNet	7817000
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3105000
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5116000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	255720000
CY2018Q4	us-gaap	Assets Current AssetsCurrent	237512000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11854000
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9274000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9047000
CY2019Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	29503000
CY2018Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	44255000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	178000
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	204000
CY2019Q4	us-gaap	Assets Assets	306302000
CY2018Q4	us-gaap	Assets Assets	291245000
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6247000
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	12150000
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	33480000
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30551000
CY2019Q4	coll	Accrued Rebates Returns And Discounts Current AccruedRebatesReturnsAndDiscountsCurrent	157549000
CY2018Q4	coll	Accrued Rebates Returns And Discounts Current AccruedRebatesReturnsAndDiscountsCurrent	144783000
CY2019Q4	us-gaap	Loans Payable Current LoansPayableCurrent	3833000
CY2018Q4	us-gaap	Loans Payable Current LoansPayableCurrent	1642000
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	656000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	201765000
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	189126000
CY2019Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	7667000
CY2018Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	9858000
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9438000
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	676000
CY2019Q4	us-gaap	Liabilities Liabilities	218870000
CY2018Q4	us-gaap	Liabilities Liabilities	199660000
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33678840
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33265629
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	34000
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	33000
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	447297000
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	428729000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-359899000
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-337177000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	87432000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	91585000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	306302000
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	291245000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	296701000
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	280413000
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28476000
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	193660000
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	165677000
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2595000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10340000
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8661000
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8572000
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	116449000
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	126760000
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	92756000
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	320449000
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	301098000
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	103923000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-23748000
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-20685000
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-75447000
CY2019	us-gaap	Interest Expense InterestExpense	909000
CY2018	us-gaap	Interest Expense InterestExpense	20130000
CY2019	us-gaap	Investment Income Net InvestmentIncomeNet	1935000
CY2018	us-gaap	Investment Income Net InvestmentIncomeNet	1687000
CY2017	us-gaap	Investment Income Net InvestmentIncomeNet	582000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-22722000
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-39128000
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-74865000
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.68
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.19
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.47
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33453844
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	32953808
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	30265262
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	134908000
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	736000
CY2017	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1141000
CY2017	coll	Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units Value StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsValue	-68000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1253000
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	34283000
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7945000
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-74865000
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	104080000
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4255000
CY2018	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1117000
CY2018	coll	Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units Value StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsValue	-560000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13778000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	8043000
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-39128000
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	91585000
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2046000
CY2019	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	817000
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	87432000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-22722000
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-39128000
CY2019	coll	Stock Withheld For Employee Taxes Upon Vesting Of Restricted Stock Units Value StockWithheldForEmployeeTaxesUponVestingOfRestrictedStockUnitsValue	-822000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16528000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-22722000
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-219000
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-74865000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14752000
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	109834000
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	731000
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1074000
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	594000
CY2017	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	1845000
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	68231000
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7840000
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1826000
CY2017	coll	Amortization Of Incentive From Lessor AmortizationOfIncentiveFromLessor	34000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	16528000
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	13778000
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	7945000
CY2019	coll	Operating Lease Payments Non Cash OperatingLeasePaymentsNonCash	313000
CY2018	us-gaap	Paid In Kind Interest PaidInKindInterest	19281000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4993000
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	497000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2037000
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	166000
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1057000
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5903000
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	6465000
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3422000
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6056000
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	18995000
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-527000
CY2019	coll	Increase Decrease In Accrued Rebates Returns And Discounts IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts	12766000
CY2018	coll	Increase Decrease In Accrued Rebates Returns And Discounts IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts	106593000
CY2017	coll	Increase Decrease In Accrued Rebates Returns And Discounts IncreaseDecreaseInAccruedRebatesReturnsAndDiscounts	15784000
CY2019	coll	Increase Decrease In Operating Lease Asset And Liabilities IncreaseDecreaseInOperatingLeaseAssetAndLiabilities	734000
CY2017	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-4944000
CY2019	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-676000
CY2018	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	676000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	27783000
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	169390000
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-67018000
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	18877000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6438000
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5477000
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	990000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6438000
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24354000
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-990000
CY2019	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	817000
CY2018	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	1117000
CY2017	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	1141000
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2046000
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4255000
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	736000
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	822000
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	560000
CY2017	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	68000
CY2018	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	30000
CY2017	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1198000
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-30000
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	34338000
CY2018	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	10021000
CY2017	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2667000
CY2018	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	132000000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2041000
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-117197000
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	33480000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	23386000
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	27839000
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-34528000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	146633000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118794000
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153322000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	170019000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	146633000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118794000
CY2018	coll	Cash Paid For Offering Costs CashPaidForOfferingCosts	30000
CY2017	coll	Cash Paid For Offering Costs CashPaidForOfferingCosts	1228000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	709000
CY2018	us-gaap	Interest Paid Net InterestPaidNet	582000
CY2017	us-gaap	Interest Paid Net InterestPaidNet	139000
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	134000
CY2018	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	3261000
CY2017	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	216000
CY2019	coll	Operating Lease Assets Assumed OperatingLeaseAssetsAssumed	9957000
CY2019	coll	Operating Lease Liabilities Assumed OperatingLeaseLiabilitiesAssumed	10691000
CY2018	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	22406000
CY2018	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	254000
CY2018	coll	Warrant Issued WarrantIssued	8043000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-359899000
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Use of Estimates</b></p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-weight:bold;visibility:hidden;"></span></p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;">The preparation of consolidated financial statements in accordance with GAAP requires the Company to make estimates and assumptions that impact the reported amounts of assets, liabilities, revenues, costs and expenses and the disclosure of contingent assets and liabilities in the Company’s consolidated financial statements and accompanying notes. Estimates in the Company’s consolidated financial statements include revenue recognition, including the estimates of product returns, units prescribed, discounts and allowances related to commercial sales of products, estimates of useful lives with respect to intangible assets, accounting for stock based compensation, contingencies, impairment of intangible assets and tax valuation reserves. The Company bases estimates and assumptions on historical experience when available and on various factors that it believes to be reasonable under the circumstances. The Company evaluates its estimates and assumptions on an ongoing basis. The Company’s actual results may differ from these estimates under different assumptions or conditions.</p>
CY2018Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0
CY2019Q4	us-gaap	Fair Value Assets Level1 To Level2 Transfers Amount FairValueAssetsLevel1ToLevel2TransfersAmount	0
CY2019	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><b style="font-weight:bold;">Concentration of Credit Risk</b></p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-weight:bold;visibility:hidden;"></span></p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;">Financial instruments, which potentially subject the Company to significant concentration of credit risk, consist primarily of cash and cash equivalents and accounts receivable. The Company maintains its cash deposits primarily with one reputable and nationally recognized financial institution. In addition, as of December 31, 2019, the Company’s cash equivalents were invested in money market funds. The Company has not experienced any material losses in such accounts and management believes that the Company is not exposed to significant credit risk due to the financial position of the financial institutions in which those deposits are held. </p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;"></span></p><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;">Three customers comprised 10% or more of the Company’s accounts receivable balance as of December 31, 2019. These customers comprised 51%, 27% and 19% of the accounts receivable balance, respectively. The same three customers comprised 10% or more of the Company’s revenue during the year ended December 31, 2019. These customers comprised 34%, 31% and 30% of revenue, respectively. To date, the Company has not experienced any losses with respect to the collection of its accounts receivable and believes that its entire accounts receivable balance is collectible as of December 31, 2019. The Company has no <span style="-sec-ix-hidden:_72be355a_7b19_4e84_9eb5_b4934aed3aa5"><span style="color:#000000;font-family:'Times New Roman';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;">financial</span></span> instruments with off-balance sheet risk of loss.</p>
CY2019Q4	us-gaap	Fair Value Disclosure Offbalance Sheet Risks Amount Asset FairValueDisclosureOffbalanceSheetRisksAmountAsset	0
CY2019Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	94841000
CY2018Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	92914000
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	97000
CY2019Q4	us-gaap	Inventory Net InventoryNet	9643000
CY2018Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0
CY2019Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0
CY2018	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0
CY2019	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0
CY2019Q1	us-gaap	Lease Practical Expedients Package LeasePracticalExpedientsPackage	true
CY2018	us-gaap	Revenue Practical Expedient Incremental Cost Of Obtaining Contract RevenuePracticalExpedientIncrementalCostOfObtainingContract	true
CY2019	us-gaap	Revenue Practical Expedient Incremental Cost Of Obtaining Contract RevenuePracticalExpedientIncrementalCostOfObtainingContract	true
CY2018Q1	coll	Assumed Liability Related To Product Sales AssumedLiabilityRelatedToProductSales	22660000
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	296701000
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	280413000
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	28476000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-22722000
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-39128000
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-74865000
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33453844
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	32953808
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	30265262
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.68
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.19
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.47
CY2019Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	795000
CY2018Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	496000
CY2019Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1427000
CY2018Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	671000
CY2019Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7421000
CY2018Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6650000
CY2019Q4	us-gaap	Inventory Net InventoryNet	9643000
CY2018Q4	us-gaap	Inventory Net InventoryNet	7817000
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1222000
CY2018Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3035000
CY2019Q4	coll	Prepaid Development Costs PrepaidDevelopmentCosts	474000
CY2018Q4	coll	Prepaid Development Costs PrepaidDevelopmentCosts	78000
CY2019Q4	us-gaap	Prepaid Insurance PrepaidInsurance	414000
CY2018Q4	us-gaap	Prepaid Insurance PrepaidInsurance	340000
CY2019Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	854000
CY2018Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	655000
CY2019Q4	us-gaap	Other Assets Current OtherAssetsCurrent	141000
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1008000
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3105000
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5116000
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11111000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2288000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	14142000
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1837000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11854000
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	9274000
CY2019	us-gaap	Depreciation Depreciation	731000
CY2018	us-gaap	Depreciation Depreciation	1074000
CY2017	us-gaap	Depreciation Depreciation	336000
CY2019	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	280000
CY2018	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	905000
CY2018	coll	Upfront Cash Paid For Asset Acquisition UpfrontCashPaidForAssetAcquisition	18877000
CY2018	coll	Minimum Royalty Payment Liability MinimumRoyaltyPaymentLiability	112719000
CY2018	coll	Asset Acquisition Costs Accumulated Rebates Incentives Trade Allowances And Chargebacks Assumed AssetAcquisitionCostsAccumulatedRebatesIncentivesTradeAllowancesAndChargebacksAssumed	22660000
CY2018	coll	Asset Acquisition Costs Accumulated Warrant Issued AssetAcquisitionCostsAccumulatedWarrantIssued	8043000
CY2018	coll	Asset Acquisition Costs Accumulated Total AssetAcquisitionCostsAccumulatedTotal	162299000
CY2018Q4	coll	Royalty Payable Remainder Of Fiscal Year RoyaltyPayableRemainderOfFiscalYear	132000000
CY2018Q4	coll	Interest Expense Recognized Relating To Royalty Payments Prior To Third Amendment InterestExpenseRecognizedRelatingToRoyaltyPaymentsPriorToThirdAmendment	19281000
CY2018Q4	coll	Asset Acquisition Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssets	154089000
CY2018Q4	coll	Asset Acquisition Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	6223000
CY2018Q4	coll	Asset Acquisition Recognized Identifiable Assets Acquired And Liabilities Assumed Prepaid Expenses AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPrepaidExpenses	1987000
CY2018Q4	coll	Asset Acquisition Recognized Identifiable Assets Acquired And Liabilities Assumed Net AssetAcquisitionRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	162299000
CY2017Q4	coll	Royalty Payment Due RoyaltyPaymentDue	537000000
CY2017Q4	coll	Royalty Payable Remainder Of Fiscal Year RoyaltyPayableRemainderOfFiscalYear	132000000
CY2017Q4	coll	Royalty Payable Year Two RoyaltyPayableYearTwo	135000000
CY2017Q4	coll	Royalty Payable Year Three RoyaltyPayableYearThree	135000000
CY2017Q4	coll	Royalty Payable Year Four RoyaltyPayableYearFour	135000000
CY2017Q4	coll	Royalty Payable Fair Value RoyaltyPayableFairValue	482300000
CY2017Q4	coll	Discounted Cash Flow Rate DiscountedCashFlowRate	0.057
CY2017Q4	coll	Interest Expense Royalty InterestExpenseRoyalty	54700000
CY2018Q4	coll	Interest Expense Recognized Relating To Royalty Payments Prior To Third Amendment InterestExpenseRecognizedRelatingToRoyaltyPaymentsPriorToThirdAmendment	19281000
CY2018Q4	coll	Amortization Expense Recognized Relating To Royalty Payments Prior To Third Amendment AmortizationExpenseRecognizedRelatingToRoyaltyPaymentsPriorToThirdAmendment	107662000
CY2019	coll	Summary Of Costs Included In Acquired Asset SummaryOfCostsIncludedInAcquiredAsset	<p style="font-family:'Times New Roman';font-size:10pt;min-height:0.0pt;margin:14pt 0pt 0pt 0pt;"><span style="font-size:0pt;line-height:1.19;visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:75.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:middle;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:middle;width:22.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;margin-bottom:0pt;visibility:hidden;"></span></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:middle;width:75.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Costs included in Nucynta Intangible Asset:</p></td><td style="background-color:#cceeff;vertical-align:middle;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="background-color:#cceeff;vertical-align:middle;width:22.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td></tr><tr><td style="vertical-align:middle;width:75.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 6pt;">Upfront cash paid</p></td><td style="vertical-align:middle;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:22.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">10,000</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:middle;width:75.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 6pt;">Transaction costs</p></td><td style="background-color:#cceeff;vertical-align:middle;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="background-color:#cceeff;vertical-align:middle;width:22.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">667</p></td></tr><tr><td style="vertical-align:middle;width:75.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 6pt;"><span style="line-height:1.19;">Minimum royalty payment obligation </span><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:middle;width:2.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="vertical-align:middle;width:22.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">482,300</p></td></tr><tr><td style="background-color:#cceeff;vertical-align:middle;width:75.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;margin:0.05pt 0pt 0.05pt 6pt;"><span style="line-height:1.19;">Rebates, incentives, trade allowances and chargebacks assumed </span><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="background-color:#cceeff;vertical-align:middle;width:2.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 0pt 0.05pt 0pt;"><span style="margin-bottom:0pt;visibility:hidden;"></span></p></td><td style="background-color:#cceeff;vertical-align:middle;width:22.11%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">22,660</p></td></tr><tr><td style="vertical-align:middle;width:75.29%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">Total cost:</p></td><td style="vertical-align:middle;width:2.58%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0.05pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:middle;width:22.11%;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-align:right;margin:0.05pt 3pt 0.05pt 0pt;">515,627</p></td></tr></table><p style="font-family:'Times New Roman';font-size:12pt;line-height:1.19;margin:0pt;"><span style="margin-bottom:5pt;margin-top:5pt;visibility:hidden;"></span></p><table style="border-collapse:collapse;font-family:'Times New Roman';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman';font-size:7pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="color:#000000;font-family:'Times New Roman';font-size:7pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;">Represents </span><span style="color:#000000;font-family:'Times New Roman';font-size:7pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;">$537,000</span><span style="color:#000000;font-family:'Times New Roman';font-size:7pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;"> of minimum royalty payments owed under the Nucynta Commercialization Agreement discounted for present value adjustments of </span><span style="color:#000000;font-family:'Times New Roman';font-size:7pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;">$54,700</span><span style="color:#000000;font-family:'Times New Roman';font-size:7pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;">.</span></td></tr></table><p style="font-family:'Times New Roman';font-size:12pt;line-height:1.19;margin:0pt;"><span style="font-size:7pt;margin-bottom:5pt;margin-top:5pt;visibility:hidden;"></span></p><table style="border-collapse:collapse;font-family:'Times New Roman';font-size:12pt;line-height:1.19;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman';font-size:7pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="color:#000000;font-family:'Times New Roman';font-size:7pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;">Represents </span><span style="color:#000000;font-family:'Times New Roman';font-size:7pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;">$22,660</span><span style="color:#000000;font-family:'Times New Roman';font-size:7pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;"> of liabilities assumed related to sales of Nucynta Products that occurred prior to the closing date of January 9, 2018, for which the Company is liable under the terms of the Nucynta Commercialization Agreement. This assumed liability, representing </span><span style="color:#000000;font-family:'Times New Roman';font-size:7pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;">$22,406</span><span style="color:#000000;font-family:'Times New Roman';font-size:7pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;"> of assumed rebates and incentives and </span><span style="color:#000000;font-family:'Times New Roman';font-size:7pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;">$254</span><span style="color:#000000;font-family:'Times New Roman';font-size:7pt;font-style:normal;font-weight:normal;line-height:1.19;text-align:left;"> of assumed trade allowances and chargebacks, was recorded as a component of the intangible asset acquired as part of the Nucynta Commercialization Agreement.</span></td></tr></table>
CY2018Q1	coll	Upfront Cash Paid For Asset Acquisition UpfrontCashPaidForAssetAcquisition	10000000
CY2018Q1	coll	Asset Acquisition Costs Accumulated Transaction Costs AssetAcquisitionCostsAccumulatedTransactionCosts	667000
CY2018Q1	coll	Minimum Royalty Payment Liability MinimumRoyaltyPaymentLiability	482300000
CY2018Q1	coll	Asset Acquisition Costs Accumulated Rebates Incentives Trade Allowances And Chargebacks Assumed AssetAcquisitionCostsAccumulatedRebatesIncentivesTradeAllowancesAndChargebacksAssumed	22660000
CY2018Q1	coll	Asset Acquisition Costs Accumulated Total AssetAcquisitionCostsAccumulatedTotal	515627000
CY2018Q1	coll	Royalty Payable Remainder Of Fiscal Year RoyaltyPayableRemainderOfFiscalYear	537000000
CY2018Q1	coll	Interest Expense Royalty InterestExpenseRoyalty	54700000
CY2018Q1	coll	Asset Acquisition Costs Accumulated Rebates Incentives Trade Allowances And Chargebacks Assumed AssetAcquisitionCostsAccumulatedRebatesIncentivesTradeAllowancesAndChargebacksAssumed	22660000
CY2018Q1	coll	Asset Acquisition Costs Accumulated Rebates And Incentives AssetAcquisitionCostsAccumulatedRebatesAndIncentives	22406000
CY2018Q1	coll	Asset Acquisition Costs Accumulated Trade Allowances And Chargebacks Assumed AssetAcquisitionCostsAccumulatedTradeAllowancesAndChargebacksAssumed	254000
CY2018Q4	coll	Royalty Payable Remainder Of Fiscal Year RoyaltyPayableRemainderOfFiscalYear	132000000
CY2018Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1041667
CY2018Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	19.20
CY2019	coll	Asset Acquisition Costs Accumulated Warrant Issued AssetAcquisitionCostsAccumulatedWarrantIssued	8043000
CY2018Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P4Y
CY2019	coll	Amortization Expense Recognized Prior To Third Amendment AmortizationExpenseRecognizedPriorToThirdAmendment	107662000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14752000
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	109834000
CY2019	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P2Y
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	14752000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	14751000
CY2019Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	21893000
CY2018Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	15138000
CY2019Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	4047000
CY2018Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	4286000
CY2019Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	1650000
CY2018Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	1806000
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1154000
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1544000
CY2019Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	775000
CY2018Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	2193000
CY2019Q4	us-gaap	Interest Payable Current InterestPayableCurrent	473000
CY2018Q4	us-gaap	Interest Payable Current InterestPayableCurrent	274000
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	308000
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	480000
CY2018Q4	coll	Accrued Inventory Current AccruedInventoryCurrent	3745000
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3180000
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1085000
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	33480000
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	30551000
CY2019	coll	Loss Contingency Stay Period Before Final Federal Drug Administration Approval Can Be Issued If Patent Infringement Litigation Elected LossContingencyStayPeriodBeforeFinalFederalDrugAdministrationApprovalCanBeIssuedIfPatentInfringementLitigationElected	P30M
CY2019	coll	Loss Contingency Stay Period Before Final Federal Drug Administration Approval Can Be Issued If Patent Infringement Litigation Elected LossContingencyStayPeriodBeforeFinalFederalDrugAdministrationApprovalCanBeIssuedIfPatentInfringementLitigationElected	P30M
CY2018Q1	coll	Period Stay Of Approval And Opportunity To Litigate PeriodStayOfApprovalAndOpportunityToLitigate	P45D
CY2018Q2	us-gaap	Loss Contingency New Claims Filed Number LossContingencyNewClaimsFiledNumber	2
CY2018Q3	us-gaap	Loss Contingency New Claims Filed Number LossContingencyNewClaimsFiledNumber	4
CY2018Q3	us-gaap	Loss Contingency New Claims Filed Number LossContingencyNewClaimsFiledNumber	2
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3833000
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3833000
CY2019Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	3834000
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	11500000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9047000
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	10094000
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	1446000
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	752000
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	283000
CY2019	us-gaap	Lease Cost LeaseCost	2481000
CY2019	coll	Schedule Of Lease Quantitative Details ScheduleOfLeaseQuantitativeDetails	<p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;"></span></p><table style="border-collapse:collapse;font-size:16pt;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:28.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-size:1pt;visibility:hidden;"></span></p></div></div></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><span style="visibility:hidden;"></span></p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Calibri';font-size:11pt;visibility:hidden;"></span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:30.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">As of December 31, </b></p></td></tr><tr><td style="background-color:auto;vertical-align:bottom;width:67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;">Lease Term and Discount Rate:</p></td><td style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Calibri';font-size:11pt;visibility:hidden;"></span></p></td><td colspan="2" style="background-color:auto;vertical-align:bottom;white-space:nowrap;width:30.61%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-weight:bold;">2019</b></p></td></tr><tr><td style="background-color:#cceeff;vertical-align:bottom;width:67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;">Weighted-average remaining lease term — operating leases (years)</p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Calibri';font-size:11pt;visibility:hidden;"></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Calibri';font-size:11pt;visibility:hidden;"></span></p></td><td style="background-color:#cceeff;vertical-align:bottom;white-space:nowrap;width:28.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9.6</p></td></tr><tr><td style="vertical-align:bottom;width:67%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;">Weighted-average discount rate — operating leases</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Calibri';font-size:11pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Calibri';font-size:11pt;visibility:hidden;"></span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:28.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman';font-size:10pt;line-height:1.19;text-align:right;margin:0pt 3pt 0pt 0pt;">6.1%</p></td></tr></table>
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y7M6D
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.061
CY2017	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	34283000
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	1133000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1252000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1290000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1328000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1366000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1404000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	6858000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	13498000
CY2019Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	3404000
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	10094000
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1032000
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1305000
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1261000
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1299000
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1337000
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	8423000
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	14657000
CY2019Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	7194215
CY2018Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	6540491
CY2017Q1	coll	Sale Of Stock Consideration Received If Additional Shares Are Issued SaleOfStockConsiderationReceivedIfAdditionalSharesAreIssued	60000000
CY2017	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3126998
CY2017Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	11.36
CY2018	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0
CY2019	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	0
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3585856
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	16.20
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	11170000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1095908
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	15.22
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	201308
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.16
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	524569
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	18.00
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1506000
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3970000
CY2019	coll	Employee Stock Purchase Plan Purchase Price Percentage EmployeeStockPurchasePlanPurchasePricePercentage	0.85
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1100000
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	21257000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2094720
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	15.05
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y7M6D
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	13020000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.07
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	14.51
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	7.86
CY2019	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	74142
CY2019	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	817000
CY2019	coll	Employee Stock Purchase Plan Compensation Expense EmployeeStockPurchasePlanCompensationExpense	358000
CY2018	coll	Employee Stock Purchase Plan Compensation Expense EmployeeStockPurchasePlanCompensationExpense	493000
CY2017	coll	Employee Stock Purchase Plan Compensation Expense EmployeeStockPurchasePlanCompensationExpense	380000
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16528000
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13778000
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7945000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.024
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.026
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.020
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.633
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.648
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.710
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3400
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0559
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0589
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0393
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.0324
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.0251
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.0249
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.4332
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0183
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0052
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.0053
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.2518
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.2490
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0735
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	66553000
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	82501000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3768000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	4364000
CY2019Q4	coll	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	2630000
CY2019Q4	coll	Deferred Tax Assets Operating Lease Assets DeferredTaxAssetsOperatingLeaseAssets	-2357000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	14286000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	4676000
CY2019Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	92000
CY2018Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	269000
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	84972000
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	91810000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	77285000
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	80290000
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	7687000
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	11520000
CY2019Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	7687000
CY2018Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	11520000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	5796000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3137000
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances	0
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-3005000
CY2019Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	4044000
CY2017	coll	Unrecognized Tax Benefits Increase Resulting From Irs Examination UnrecognizedTaxBenefitsIncreaseResultingFromIrsExamination	902000
CY2017	coll	Unrecognized Tax Benefits Increase Resulting From Change In Tax Rate UnrecognizedTaxBenefitsIncreaseResultingFromChangeInTaxRate	235000
CY2018	coll	Net Operating Loss Carryforwards Increase Decrease NetOperatingLossCarryforwardsIncreaseDecrease	36000
CY2018	coll	Net Operating Loss Carryforwards Increase Decrease NetOperatingLossCarryforwardsIncreaseDecrease	36000
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	502000
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1364000
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	76000
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	64000
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	57000
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1307000
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	24000
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	902000
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	578000
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	502000
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1364000
CY2019Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	549000
CY2018Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	481000
CY2017Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	680000
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1170000
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1208000
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	969000
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74516000
CY2019Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	75040000
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	72942000
CY2019Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74203000
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	49164000
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	48654000
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	84508000
CY2019Q2	us-gaap	Costs And Expenses CostsAndExpenses	80048000
CY2019Q3	us-gaap	Costs And Expenses CostsAndExpenses	79317000
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	46754000
CY2018Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2249000
CY2019Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	49088000
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2992000
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2459000
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2491000
CY2019Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2398000
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	32352000
CY2019Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	28935000
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	30072000
CY2019Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	25090000
CY2019Q4	us-gaap	Costs And Expenses CostsAndExpenses	76576000
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9992000
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5008000
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6375000
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2373000
CY2019Q1	us-gaap	Interest Expense InterestExpense	234000
CY2019Q2	us-gaap	Interest Expense InterestExpense	236000
CY2019Q3	us-gaap	Interest Expense InterestExpense	228000
CY2019Q4	us-gaap	Interest Expense InterestExpense	211000
CY2019Q1	us-gaap	Investment Income Net InvestmentIncomeNet	526000
CY2019Q2	us-gaap	Investment Income Net InvestmentIncomeNet	532000
CY2019Q3	us-gaap	Investment Income Net InvestmentIncomeNet	494000
CY2019Q4	us-gaap	Investment Income Net InvestmentIncomeNet	383000
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-9700000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-4712000
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-6109000
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-2201000
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33331917
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33397709
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33481923
CY2019Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33600566
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.29
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.14
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.18
CY2019Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.07
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	63749000
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	73061000
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	70176000
CY2018Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	73427000
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	43106000
CY2018Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	46838000
CY2018Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	46007000
CY2018Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	29726000
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2268000
CY2018Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2237000
CY2018Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1907000
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-7293000
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-11186000
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	11001000
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	31582000
CY2018Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	31279000
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	33448000
CY2018Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	30451000
CY2018Q1	us-gaap	Costs And Expenses CostsAndExpenses	76956000
CY2018Q2	us-gaap	Costs And Expenses CostsAndExpenses	80354000
CY2018Q3	us-gaap	Costs And Expenses CostsAndExpenses	81362000
CY2018Q4	us-gaap	Costs And Expenses CostsAndExpenses	62426000
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-13207000
CY2018Q1	us-gaap	Interest Expense InterestExpense	5700000
CY2018Q2	us-gaap	Interest Expense InterestExpense	6158000
CY2018Q3	us-gaap	Interest Expense InterestExpense	5868000
CY2018Q4	us-gaap	Interest Expense InterestExpense	2404000
CY2018Q1	us-gaap	Investment Income Net InvestmentIncomeNet	255000
CY2018Q2	us-gaap	Investment Income Net InvestmentIncomeNet	391000
CY2018Q3	us-gaap	Investment Income Net InvestmentIncomeNet	552000
CY2018Q4	us-gaap	Investment Income Net InvestmentIncomeNet	489000
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-18652000
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	-13060000
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-16502000
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	9086000
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32903674
CY2018Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32967718
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33012174
CY2018Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33250180
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.50
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32903674
CY2018Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32967718
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33012174
CY2018Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33769765
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.57
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.50
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27

Files In Submission

Name	View Source	Status
0001558370-20-001625-index-headers.html	Edgar Link	pending
0001558370-20-001625-index.html	Edgar Link	pending
0001558370-20-001625.txt	Edgar Link	pending
0001558370-20-001625-xbrl.zip	Edgar Link	pending
coll-20191231.xsd	Edgar Link	pending
coll-20191231x10k3059df.htm	Edgar Link	pending
coll-20191231x10k3059df001.jpg	Edgar Link	pending
coll-20191231x10k3059df003.jpg	Edgar Link	pending
coll-20191231x10k3059df_htm.xml	Edgar Link	completed
coll-20191231_cal.xml	Edgar Link	unprocessable
coll-20191231_def.xml	Edgar Link	unprocessable
coll-20191231_lab.xml	Edgar Link	unprocessable
coll-20191231_pre.xml	Edgar Link	unprocessable
ex-21d1.htm	Edgar Link	pending
ex-23d1.htm	Edgar Link	pending
ex-31d1.htm	Edgar Link	pending
ex-31d2.htm	Edgar Link	pending
ex-32d1.htm	Edgar Link	pending
ex-32d2.htm	Edgar Link	pending
ex-4d5.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$COLL
COLLEGIUM PHARMACEUTICAL, INC Stock $coll

2019 Form 10-K Financial Statement

#000155837020001625 Filed on February 27, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COLL COLLEGIUM PHARMACEUTICAL, INC Stock $coll

2019 Form 10-K Financial Statement

#000155837020001625 Filed on February 27, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COLL
COLLEGIUM PHARMACEUTICAL, INC Stock $coll